Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

ABS Biotechnologies

ABS Biotechnologies GmbH offers a drug screening platform using blood vessel cells for precision medicine.
2022
2-10
Tulln, Niederosterreich, Austria
BiotechnologynologyHealth CareMedicalPrecision Medicine

Investment Funding

Revenue

$1M to $10M

People

Founders